Adam Lenkowsky, Executive Vice President, Chief Commercial Officer at Bristol Myers Squibb, shared a post on LinkedIn:
“Few moments are as humbling and inspiring as witnessing our colleagues cross the finish line of the Coast 2 Coast 4 Cancer ride. C2C4C is not just a physical journey – it’s a powerful expression of who we are and why we do what we do.
Each mile cycled represents the resilience of patients, the dedication of caregivers, and the unwavering commitment of our teams to advance cancer research. Watching our colleagues train, ride, and fundraise – often in honor of loved ones impacted by cancer – reminds me that our purpose is deeply personal. It’s what connects us across geographies, roles, and backgrounds.
This year, with more than 300 riders from 33 nations participating, we’re not just raising funds – we’re raising hope. More than $21 million donated globally is a testament to what’s possible when we come together with purpose. And as we mark 12 years of C2C4C, I’m reminded that this event embodies the very heart of our patient-centric culture.
To me, C2C4C is more than a tradition – it’s a reflection of our values in motion. I’ve had the privilege to participate in multiple rides during my years with BMS, and each one is a reminder that every effort, every pedal stroke, and every dollar raised brings us closer to a future where patients everywhere have more options and more hope.
Please join me in congratulating this year’s riders. To learn more about this movement, visit BMS.com.”
